Genmab — September 2020

[GeorgeBest]

Here is the agreement https://ir.genmab.com/news-releases/news-release-details/genmab-signs-agreement-janssen-next-generation-cd38-antibody/

[GeorgeBest]

There are restrictions. Hexa-cd38 can not go in direct competion with DARZALEX

[Darvin]

Opkøb kan være venlige, fjendtlige eller noget man får svært ved at sige nej til. Aktionærerne bestemmer

[StockBull]

Ja det må man sige men det kan vel være taktisk. Antager at fornuftig data kan skørpe JNJ interesse for et opkøb og der kommer som bekendt løbende data som potentielt kan medvirke til beslutning om evt. opkøb

[Mcjean]

@Darvin forklar mig hvorfor de kan vinde tvisten om patent til 35 hvis de modsiger at have noget med Halo at gøre, det er alene Halo der giver patent til 35 og når patentet udløber i 2029 så må alle andre kombinere Dara med hvad som helst. De kan ikke både få i hoved og sæk, men enig i at alt kan lade sig gøre, virker bare ikke særlig sandsynligt i min optik.

[GeorgeBest]

Should Janssen not exercise its option, the terms of the agreement allow Genmab to continue to develop and commercialize HexaBody-CD38 for DARZALEX-resistant patients, and in all other indications except those multiple myeloma or amyloidosis indications where DARZALEX is either approved or is being actively developed.

[nohope]

Jeg burde have vidst at medicin ikke handlede om medicin men om jura.

[nohope]

GEN ophører jo nærmest med at eksistere i 2030

[GeorgeBest]

Now we know why Jan want to develope Hexa-cd38 in B-cell lymphoma...

[GeorgeBest]

But wouldn’t that be an overlap with Epcoritamab?

[Zipo]

Test

[E_L]

I now really wonder why Genmab thought that non-compete clause with Dara was acceptable...

[E_L]

by the way, Symphony Health
data anyone...?

[Sukkeralf]

Patent bollocks - i just hate it You have no chance just cold water right in the face !!

[w]

Hvem af partnerne har indgivet sagen?

[GeorgeBest]

Genmab

[BioShare]

Formentlig Genmab - JNJ er jo begyndt at reducere royalty-betalingen med HALO-andelen.

[Zipo]

https://ir.genmab.com/news-releases/news-release-details/genmab-commences-bindin
g-arbitration-two-matters-under-license

[PederT]

Det står også i deres press release, at Genmab har påbegyndt sagen.

[Zipo]

While Genmab intends to vigorously protect its rights under the agreement, the outcome of any arbitration proceeding, as well as its duration, is inherently
uncertain.